Arcutis Biotherapeutics, Inc. (ARQT) — Institutional Holders, Q2 2026
273 institutional investment managers reported a ARQT position on SEC Form 13F-HR for the quarter ended June 30, 2026, with a combined reported value of $3.4B. Every filer is listed below, ranked by position value, 100 per page; this page shows ranks 1 to 100. Put and call option positions are excluded, and a firm filing several lots or share classes is shown once with its total.
ARQT in Q2 2026: what funds did
Funds that filed a 13F for both Q1 2026 and Q2 2026, by what they did with the common stock. Share counts are adjusted for any split between the two quarters; dollar figures are the change in shares at this quarter’s price.
Biggest buyers
- ORBIMED ADVISORSNew · +2,042,000 sh+$53.5M
- D. E. ShawAdded · +1,453,387 sh+$38.1M
- BlackRockAdded · +1,345,055 sh+$35.3M
- CITADEL ADVISORSAdded · +1,144,408 sh+$30.0M
- Jones Hill CapitalNew · +1,089,701 sh+$28.6M
Biggest sellers
- GILDER GAGNON HOWETrimmed · -2,990,799 sh-$78.4M
- MARSHALL WACE, LLPTrimmed · -1,984,912 sh-$52.0M
- DRIEHAUS CAPITAL MANAGEMENTTrimmed · -1,347,603 sh-$35.3M
- JENNISON ASSOCIATESTrimmed · -761,712 sh-$20.0M
- MPM BioImpactSold out · -733,966 sh-$19.2M
ARQT 13F holders ranked 1–100 of 273
| # | Institution | Shares | Value | % of portfolio | QoQShares vs Q1 2026 |
|---|---|---|---|---|---|
| 1 | SUVRETTA CAPITAL MANAGEMENT#1 · 12,437,000 sh | 12,437,000 | $326.1M | 5.96% | +0.9% |
| 2 | BlackRock#2 · 10,545,466 sh | 10,545,466 | $276.5M | <0.01% | +14.6% |
| 3 | Frazier Life Sciences Management, L.P.#3 · 9,874,511 sh | 9,874,511 | $258.9M | 5.64% | 0.0% |
| 4 | Rubric Capital Management#4 · 8,271,577 sh | 8,271,577 | $216.9M | 1.99% | 0.0% |
| 5 | Polar Capital Plc#5 · 6,606,945 sh | 6,606,945 | $173.2M | 0.41% | +16.6% |
| 6 | STATE STREET#6 · 5,822,840 sh | 5,822,840 | $152.7M | <0.01% | -7.5% |
| 7 | VANGUARD CAPITAL MANAGEMENT#7 · 4,988,756 sh | 4,988,756 | $130.8M | <0.01% | +2.4% |
| 8 | MORGAN STANLEY#8 · 4,451,014 sh | 4,451,014 | $116.7M | <0.01% | +5.5% |
| 9 | JENNISON ASSOCIATES#9 · 4,219,058 sh | 4,219,058 | $110.6M | 0.07% | -15.3% |
| 10 | D. E. Shaw#10 · 3,949,609 sh | 3,949,609 | $103.6M | 0.05% | +58.2% |
| 11 | UBS Group AG#11 · 3,333,015 sh | 3,333,015 | $87.4M | 0.01% | +0.1% |
| 12 | BANK OF AMERICA#12 · 2,987,431 sh | 2,987,431 | $78.3M | <0.01% | +34.5% |
| 13 | GEODE CAPITAL MANAGEMENT#13 · 2,982,446 sh | 2,982,446 | $78.2M | <0.01% | -2.1% |
| 14 | VANGUARD PORTFOLIO MANAGEMENT#14 · 2,429,005 sh | 2,429,005 | $63.7M | <0.01% | +24.3% |
| 15 | ORBIMED ADVISORS#15 · 2,042,000 sh | 2,042,000 | $53.5M | 0.99% | New |
| 16 | FRANKLIN RESOURCES#16 · 1,930,982 sh | 1,930,982 | $50.6M | 0.01% | -16.0% |
| 17 | AMERICAN CENTURY COMPANIES#17 · 1,925,031 sh | 1,925,031 | $50.5M | 0.02% | +31.6% |
| 18 | GOLDMAN SACHS GROUP#18 · 1,668,367 sh | 1,668,367 | $43.7M | <0.01% | +4.1% |
| 19 | Jupiter Topco#19 · 1,410,435 sh | 1,410,435 | $37.0M | 0.02% | — |
| 20 | OBERWEIS ASSET MANAGEMENT#20 · 1,372,941 sh | 1,372,941 | $36.0M | 0.74% | +0.5% |
| 21 | GILDER GAGNON HOWE#21 · 1,313,211 sh | 1,313,211 | $34.4M | 0.36% | -69.5% |
| 22 | GW&K Investment Management#22 · 1,288,018 sh | 1,288,018 | $33.8M | 0.26% | +30.3% |
| 23 | Pivotal bioVenture Partners Investment Advisor#23 · 1,265,283 sh | 1,265,283 | $33.2M | 10.78% | -6.7% |
| 24 | BAMCO#24 · 1,253,120 sh | 1,253,120 | $32.9M | 0.05% | +16.9% |
| 25 | CITADEL ADVISORS#25 · 1,160,014 sh | 1,160,014 | $30.4M | <0.01% | +7333.1% |
| 26 | FEDERATED HERMES#26 · 1,124,629 sh | 1,124,629 | $29.5M | 0.04% | +4.4% |
| 27 | Perpetual Ltd#27 · 1,109,657 sh | 1,109,657 | $29.1M | — | +22.0% |
| 28 | abrdn plc#28 · 1,098,411 sh | 1,098,411 | $28.8M | 0.04% | +70.3% |
| 29 | Jones Hill Capital#29 · 1,089,701 sh | 1,089,701 | $28.6M | 6.07% | New |
| 30 | NORTHERN#30 · 1,058,575 sh | 1,058,575 | $27.8M | <0.01% | +8.4% |
| 31 | CHARLES SCHWAB INVESTMENT MANAGEMENT#31 · 1,050,934 sh | 1,050,934 | $27.6M | <0.01% | +3.8% |
| 32 | Ensign Peak Advisors#32 · 974,534 sh | 974,534 | $25.6M | 0.04% | -21.7% |
| 33 | Candriam S.C.A.#33 · 949,839 sh | 949,839 | $24.9M | 0.11% | -12.6% |
| 34 | DRIEHAUS CAPITAL MANAGEMENT#34 · 878,426 sh | 878,426 | $23.0M | 0.13% | -60.5% |
| 35 | Nuveen#35 · 834,261 sh | 834,261 | $21.9M | <0.01% | -7.5% |
| 36 | VANGUARD FIDUCIARY#36 · 815,138 sh | 815,138 | $21.4M | <0.01% | +5.6% |
| 37 | MANUFACTURERS LIFE INSURANCE COMPANY, THE#37 · 811,752 sh | 811,752 | $21.3M | 0.02% | +61.1% |
| 38 | TWO SIGMA INVESTMENTS#38 · 663,877 sh | 663,877 | $17.4M | 0.01% | +183.3% |
| 39 | FISHMAN JAY A LTD#39 · 595,005 sh | 595,005 | $15.6M | — | +5.0% |
| 40 | MILLENNIUM MANAGEMENT#40 · 564,072 sh | 564,072 | $14.8M | <0.01% | +1043.4% |
| 41 | BNP PARIBAS FINANCIAL MARKETS#41 · 547,278 sh | 547,278 | $14.3M | <0.01% | -32.6% |
| 42 | Squarepoint Ops#42 · 537,747 sh | 537,747 | $14.1M | 0.02% | -51.3% |
| 43 | CAPITOLIS LIQUID GLOBAL MARKETS#43 · 500,000 sh | 500,000 | $13.1M | 0.06% | 0.0% |
| 44 | Nearwater Capital Markets, Ltd#44 · 486,700 sh | 486,700 | $12.8M | 0.22% | -19.9% |
| 45 | ADAGE CAPITAL PARTNERS GP, L.L.C.#45 · 466,000 sh | 466,000 | $12.2M | 0.02% | +27.3% |
| 46 | MARSHALL WACE, LLP#46 · 446,866 sh | 446,866 | $11.7M | <0.01% | -81.6% |
| 47 | Privium Fund Management B.V.#47 · 399,367 sh | 399,367 | $10.5M | 1.92% | +24.4% |
| 48 | NORGES BANK#48 · 392,300 sh | 392,300 | $10.3M | <0.01% | — |
| 49 | DEUTSCHE BANK AG\#49 · 382,682 sh | 382,682 | $10.0M | <0.01% | -1.8% |
| 50 | Patient Square Capital#50 · 370,000 sh | 370,000 | $9.7M | 1.50% | -7.6% |
| 51 | Point72 Asset Management, L.P.#51 · 362,449 sh | 362,449 | $9.5M | 0.01% | -38.7% |
| 52 | Qube Research & Technologies Ltd#52 · 361,662 sh | 361,662 | $9.5M | <0.01% | -50.1% |
| 53 | Longaeva Partners L.P.#53 · 344,796 sh | 344,796 | $9.0M | 0.20% | New |
| 54 | AQR CAPITAL MANAGEMENT#54 · 330,324 sh | 330,324 | $8.7M | <0.01% | -29.5% |
| 55 | Bank of New York Mellon#55 · 330,094 sh | 330,094 | $8.7M | <0.01% | +8.0% |
| 56 | FMR#56 · 305,969 sh | 305,969 | $8.0M | <0.01% | +9.8% |
| 57 | AMERIPRISE FINANCIAL#57 · 295,997 sh | 295,997 | $7.8M | <0.01% | +191.1% |
| 58 | PEREGRINE CAPITAL MANAGEMENT#58 · 291,447 sh | 291,447 | $7.6M | 0.25% | -4.8% |
| 59 | HEALTHCARE OF ONTARIO PENSION PLAN FUND#59 · 284,789 sh | 284,789 | $7.5M | 0.01% | -55.2% |
| 60 | FIRST ADVISORS#60 · 284,065 sh | 284,065 | $7.4M | <0.01% | -19.1% |
| 61 | Invesco Ltd.#61 · 264,907 sh | 264,907 | $6.9M | <0.01% | +89.4% |
| 62 | Walleye Capital#62 · 260,033 sh | 260,033 | $6.8M | 0.02% | +415.3% |
| 63 | BALYASNY ASSET MANAGEMENT L.P.#63 · 243,119 sh | 243,119 | $6.4M | <0.01% | New |
| 64 | PFM Health Sciences#64 · 242,069 sh | 242,069 | $6.3M | 0.54% | New |
| 65 | MYDA Advisors#65 · 240,000 sh | 240,000 | $6.3M | 0.94% | 0.0% |
| 66 | Jump Financial#66 · 235,471 sh | 235,471 | $6.2M | 0.05% | +375.1% |
| 67 | UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AME#67 · 231,186 sh | 231,186 | $6.1M | <0.01% | -2.5% |
| 68 | STATE OF WISCONSIN INVESTMENT BOARD#68 · 230,905 sh | 230,905 | $6.1M | 0.01% | +128.8% |
| 69 | Swiss National Bank#69 · 224,000 sh | 224,000 | $5.9M | <0.01% | +2.7% |
| 70 | SUSQUEHANNA INTERNATIONAL GROUP, LLP#70 · 219,815 sh | 219,815 | $5.8M | <0.01% | +96.0% |
| 71 | Pictet Asset Management Holding SA#71 · 200,275 sh | 200,275 | $5.4M | <0.01% | +45.0% |
| 72 | JUPITER ASSET MANAGEMENT LTD#72 · 202,515 sh | 202,515 | $5.3M | 0.03% | -6.8% |
| 73 | KORNITZER CAPITAL MANAGEMENT#73 · 199,683 sh | 199,683 | $5.2M | 0.11% | +13.5% |
| 74 | Woodline Partners#74 · 195,033 sh | 195,033 | $5.1M | 0.02% | 0.0% |
| 75 | Pavaki Capital Management#75 · 187,000 sh | 187,000 | $4.9M | — | 0.0% |
| 76 | PRINCIPAL FINANCIAL GROUP#76 · 183,662 sh | 183,662 | $4.8M | <0.01% | +8.8% |
| 77 | Cormorant Asset Management#77 · 175,000 sh | 175,000 | $4.6M | 0.24% | -61.1% |
| 78 | RHUMBLINE ADVISERS#78 · 170,542 sh | 170,542 | $4.5M | <0.01% | +5.8% |
| 79 | Holocene Advisors#79 · 163,732 sh | 163,732 | $4.3M | <0.01% | New |
| 80 | PRICE T ROWE ASSOCIATES#80 · 157,778 sh | 157,778 | $4.1M | <0.01% | -64.8% |
| 81 | VOLORIDGE INVESTMENT MANAGEMENT#81 · 157,429 sh | 157,429 | $4.1M | 0.02% | -70.9% |
| 82 | PDT Partners#82 · 155,075 sh | 155,075 | $4.1M | 0.21% | 0.0% |
| 83 | Vontobel Holding Ltd.#83 · 153,242 sh | 153,242 | $4.0M | — | +342.8% |
| 84 | CITIGROUP#84 · 151,394 sh | 151,394 | $4.0M | <0.01% | +213.2% |
| 85 | LOS ANGELES CAPITAL MANAGEMENT#85 · 137,929 sh | 137,929 | $3.6M | 0.01% | -10.7% |
| 86 | ESSEX INVESTMENT MANAGEMENT#86 · 137,500 sh | 137,500 | $3.6M | — | -4.5% |
| 87 | CASTLEARK MANAGEMENT#87 · 137,420 sh | 137,420 | $3.6M | 0.10% | -53.2% |
| 88 | Eversept Partners#88 · 135,355 sh | 135,355 | $3.5M | 0.18% | -76.5% |
| 89 | LAZARD ASSET MANAGEMENT#89 · 133,146 sh | 133,146 | $3.5M | <0.01% | -13.9% |
| 90 | TUDOR INVESTMENT ET AL#90 · 131,914 sh | 131,914 | $3.5M | <0.01% | New |
| 91 | ALLIANCEBERNSTEIN L.P.#91 · 136,393 sh | 136,393 | $3.2M | <0.01% | +15.4% |
| 92 | 1492 Capital Management#92 · 116,211 sh | 116,211 | $3.0M | 0.90% | -1.6% |
| 93 | SEI INVESTMENTS#93 · 114,253 sh | 114,253 | $3.0M | <0.01% | -44.6% |
| 94 | Tejara Capital Ltd#94 · 113,084 sh | 113,084 | $3.0M | 1.22% | -32.0% |
| 95 | LPL Financial#95 · 111,150 sh | 111,150 | $2.9M | <0.01% | -6.9% |
| 96 | WELLS FARGO & COMPANY#96 · 109,079 sh | 109,079 | $2.9M | <0.01% | -44.9% |
| 97 | SCHRODER INVESTMENT MANAGEMENT GROUP#97 · 104,356 sh | 104,356 | $2.8M | <0.01% | 0.0% |
| 98 | JPMORGAN CHASE#98 · 97,966 sh | 97,966 | $2.8M | <0.01% | -13.3% |
| 99 | Legal & General Group Plc#99 · 100,808 sh | 100,808 | $2.6M | <0.01% | +18.8% |
| 100 | StemPoint Capital#100 · 98,945 sh | 98,945 | $2.6M | 0.45% | -76.1% |
Funds that sold out of ARQT in Q2 2026 (36)
Held ARQT at the end of Q1 2026 and filed a Q2 2026 13F without it. Not in the list above, because they no longer hold it. Largest prior position first.
Source: Form 13F-HR filings on SEC EDGAR, Q2 2026. Values are as reported by each manager at quarter end. “% of portfolio” is the position’s share of the manager’s total reported 13F value for the same quarter. “New” means the manager filed a 13F for Q1 2026 without this position; a dash means no comparison is available. Where a manager’s own filing is internally inconsistent its value is withheld and it is listed last. 13F data shows reported holdings, not recommendations.